Preoperative chemoradiotherapy in the management of oral cancer: A review

Journal of Cranio-Maxillofacial Surgery

Volumn 36, Issue 2, 2008, Pages 75-88

  Klug, Clemens ^a   Berzaczy, Dominik ^d   Voracek, Martin ^b   Millesi, Werner ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d NONE

Author keywords

chemoradiotherapy; oral cancer; preoperative

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; MITOMYCIN C; PACLITAXEL; PEPLEOMYCIN;

ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; ORAL SURGERY; OROPHARYNX CANCER; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PUBLICATION; REVIEW; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; HUMANS; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; OROPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 39749088860     PISSN: 10105182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcms.2007.06.007     Document Type: Review

References (57)

1. Bengtson B.P., Schusterman M.A., Baldwin B.J., Miller M.J., Reece G.P., Kroll S.S., Robb G.L., and Goepfert H. Influence of prior radiotherapy on the development of postoperative complications and success of free tissue transfers in head and neck cancer reconstruction. Am J Surg 166 (1993) 326-330
2. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J.L., Greiner R.H., Giralt J., Maingon P., Rolland F., Bolla M., Cognetti F., Bourhis J., Kirkpatrick A., van Glabbeke M., and European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
3. Brun E., Zatterstrom U., Kjellen E., Wahlberg P., Willen R., Brun A., Perfekt R., and Tennvall J. Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas. Acta Oncol 40 (2001) 491-496
4. Chang D.W., Oh H.K., Robb G.L., and Miller M.J. Management of advanced mandibular osteoradionecrosis with free flap reconstruction. Head Neck 23 (2001) 830-835
5. Chang H., Leone L.A., Tefft M., and Nigri P.T. Advanced head and neck cancer: response to and toxicity of multimodality therapy. Radiology 168 (1988) 863-867
6. Chao K.S., Majhail N., Huang C.J., Simpson J.R., Perez C.A., Haughey B., and Spector G. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumour control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61 (2001) 275-280
7. Chougule P.B., Suk S., Chu Q.D., Leone L., Nigri P.T., McRae R., Lekas M., Barone A., Bhat D., and Bellino J. Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study. Cancer 74 (1994) 1927-1932
8. Cooper J.S., Pajak T.F., Forastiere A.A., Jacobs J., Campbell B.H., Saxman S.B., Kish J.A., Kim H.E., Cmelak A.J., Rotman M., Machtay M., Ensley J.F., Chao K.S., Schultz C.J., Lee N., Fu K.K., and Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
9. del Campo J.M., Felip E., Giralt J., Raspall G., Bescos S., Casado S., and Maldonado X. Preoperative simultaneous chemoradiotherapy in locally advanced cancer of the oral cavity and oropharynx. Am J Clin Oncol 20 (1997) 97-100
10. Dobrowsky W., Dobrowsky E., Strassl H., Braun O., Gritzmann N., and Scheiber V. Combined modality treatment of advanced cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 20 (1991) 239-242
11. Eckardt A., Rades D., Rudat V., Hofele C., Dammer R., Dietl B., Wildfang I., and Karstens J.H. Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-Year outcome. Mund Kiefer Gesichtschir 6 (2002) 117-121
12. El-Sayed S., and Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomised trials. J Clin Oncol 14 (1996) 838-847
13. Giralt J.L., Gonzalez J., del Campo J.M., Maldonado J., Sanz X., Pamias J., Eraso A., Bescos S., and Raspall G. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 89 (2000) 939-945
14. Glaser C.M., Millesi W., Kornek G.V., et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50 (2001) 705-715
15. Glicksman A.S., Slotman G., Doolittle III C., Clark J., Koness J., Coachman N., Posner M., DeRosa E., and Wanebo H. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 30 (1994) 1043-1050
16. Glicksman A.S., Wanebo H.J., Slotman G., Liu L., Landmann C., Clark J., Zhu T.C., Lohri A., and Probst R. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 39 (1997) 721-729
17. Goodman M.D., Tarnoff M., Kain M., and Slotman G.J. Interactions between outcomes and tumour response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group. Am J Surg 174 (1997) 527-531
18. Guelinckx P.J., Boeckx W.D., Fossion E., and Gruwez J.A. Scanning electron microscopy of irradiated recipient blood vessels in head and neck free flaps. Plast Reconstr Surg 74 (1984) 217-226
19. Hansen O., Sorensen J.A., Siemssen S.J., and Poulsen H. Importance of the time interval between radiotherapy and surgery in oral cancer. Eur J Cancer B Oral Oncol 29B (1993) 35-38
20. Hermann R.M., Krech R., Hartlapp J., Esser E., Christoph B., Muller M.K., and Wagner W. The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer. Strahlenther Onkol 177 (2001) 277-282
21. Higgins J.P.T., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
22. Jones N.F., Johnson J.T., Shestak K.C., Myers E.N., and Swartz W.M. Microsurgical reconstruction of the head and neck: interdisciplinary collaboration between head and neck surgeons and plastic surgeons in 305 cases. Ann Plast Surg 36 (1996) 37-43
23. Kessler P., Grabenbauer G., Leher A., Schultze-Mosgau S., Rupprecht S., and Neukam F.W. Patients with oral squamous cell carcinoma. Long-term survival and evaluation of quality of life-initial results obtained with two treatment protocols in a prospective study. Mund Kiefer Gesichtschir 8 (2004) 302-310
24. Kiener J.L., Hoffman W.Y., and Mathes S.J. Influence of radiotherapy on microvascular reconstruction in the head and neck region. Am J Surg 162 (1991) 404-407
25. Kirita T., Ohgi K., Shimooka H., Yamanaka Y., Tatebayashi S., Yamamoto K., Mishima K., and Sugimura M. Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results. Oral Oncol 35 (1999) 597-606
26. Kirita T., Shimooka H., Yamanaka Y., Tatebayashi S., Yamamoto K., Nishimine M., and Sugimura M. Prognostic value of response to preoperative chemoradiotherapy and residual tumour grades in tongue carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 293-300
27. Klug C., Keszthelyi D., Ploder O., Sulzbacher I., Voracek M., Wagner A., Millesi W., Kornek G., Kainberger F., Kermer C., and Selzer E. Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumour response by CT differs from histopathologic response assessment in a significant fraction of patients. Head Neck 26 (2004) 224-231
28. Klug C., Neuburg J., Glaser C., Schwarz B., Kermer C., and Millesi W. Quality of life 2-10 years after combined treatment for advanced oral and oropharyngeal cancer. Int J Oral Maxillofac Surg 31 (2002) 664-669
29. Klug C., Wutzl A., Kermer C., Voracek M., Kornek G., Selzer E., Glaser C., Poeschl P.W., Millesi W., and Ewers R. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients. Int J Oral Maxillofac Surg 34 (2005) 143-148
30. Klug C., Wutzl A., Kermer C., Ploder O., Sulzbacher I., Selzer E., Voracek M., Oeckher M., Ewers R., and Millesi W. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor. Int J Oral Maxillofac Surg 34 (2005) 262-267
31. Klug C., Berzaczy D., Voracek M., Enislidis G., Rath T., Millesi W., and Ewers R. Experience with microvascular free flaps in preoperatively irradiated tissue of the oral cavity and oropharynx in 303 patients. Oral Oncol 41 (2005) 738-746
32. Knobber D., Sack H., Stutzer H., and Rose K.G. Pre-irradiation and surgery of patients with squamous cell carcinoma of the oral cavity and oropharynx: the results of a 1973-1984 study. Strahlenther Onkol 163 (1987) 706-713
33. Kovacs A.F. Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients. Final results of a pilot study compared with a treatment-dependent prognosis index. J Craniomaxillofac Surg 34 2 (2006) 74-84
34. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10 (1987) 19-30
35. Kunkel M., Forster G.J., Reichert T.E., Kutzner J., Benz P., Bartenstein P., and Wagner W. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumour control and survival in advanced oral squamous cell carcinoma. Oral Oncol 39 (2003) 170-177
36. Kurita H., Ohtsuka A., Kobayashi H., Kurashina K., Shikama N., and Oguchi M. Non-randomised study on the effects of preoperative radiotherapy and daily administration of low-dose cisplatin against those of radiotherapy alone for oral cancer - effects on local control, control of metastases, and overall survival. Gan To Kagaku Ryoho 27 (2000) 59-64
37. Lung T., Tascau O.C., Almasan H.A., and Muresan O. Head and neck cancer, treatment, evolution and post therapeutic survival - part 2: a decade's results 1993-2002. J Craniomaxillofac Surg 35 2 (2007) 126-131
38. Mohr C., Bohndorf W., Carstens J., Harle F., Hausamen J.E., Hirche H., Kimmig H., Kutzner J., Muhling J., and Reuther J. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone: a prospective, multicentric, randomised DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 23 (1994) 140-148
39. Muller R.P., Staar S., Samek M., and Pape H.D. Simultaneous preoperative radiochemotherapy with cisplatin in advanced oral cavity carcinomas: acute response and follow-up. Recent Results Cancer Res 134 (1994) 165-172
40. Olasz L., Kwashie F., Herczegh P., Bruncsics Z., Horvath A., and Kiralyfalvi L. A comparative study of preoperative B-V-M-M chemotherapy and irradiation in advanced squamous cell cancer of the oral cavity. Neoplasma 43 (1996) 51-56
41. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
42. Pignon J.P., and Hill C. Meta-analyses of randomised clinical trials in oncology. Lancet Oncol 2 (2001) 475-482
43. Robbins K.T., Samant S., Vieira F., and Kumar P. Presurgical cytoreduction of oral cancer using intra-arterial cisplatin and limited concomitant radiation therapy (Neo-RADPLAT). Arch Otolaryngol Head Neck Surg 130 (2004) 28-32
44. Schmelzeisen R., Neukam F.W., Shirota T., Specht B., and Wichmann M. Postoperative function after implant insertion in vascularized bone grafts in maxilla and mandible. Plast Reconstr Surg 97 (1996) 719-725
45. Shikama N., Sasaki S., Nishikawa A., Koiwai K., Yoshino F., Hirase Y., Kawakami R., Kadoya M., and Oguchi M. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB). Radiology 228 (2003) 789-794
46. Sinikovic B., Hofele C., Karstens J.H., and Eckardt A. Preoperative radiochemotherapy in stage III and IV squamous cell carcinoma of the oral cavity: completed phase II study with a 6 year follow-up. Int J Oral Maxillofac Surg 34 Suppl (2005) 27
47. Slotman G.J., Doolittle C.H., and Glicksman A.S. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer: five-year results with impressive complete response rates and high survival. Cancer 69 (1992) 2736-2743
48. Szabo G., Kreidler J., Hollmann K., Kovacs A., Nemeth G., Nemeth Z., Toth-Bagi Z., and Barabas J. Intra-arterial preoperative cytostatic treatment versus preoperative irradiation: a prospective, randomised study of lingual and sublingual carcinomas. Cancer 86 (1999) 1381-1386
49. The Nordic Cochrane Centre. Review manager (RevMan) [computer program]. Version 4.2 for Windows (2003), The Nordic Cochrane Centre, Copenhagen
50. Tupchong L., Scott C.B., Blitzer P.H., Marcial V.A., Lowry L.D., Jacobs J.R., Stetz J., Davis L.W., Snow J.B., and Chandler R. Randomised study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 20 (1991) 21-28
51. Uno T., Yasuda S., Nakano K., Aruga T., Isobe K., Kawakami H., Ueno N., Kawata T., Numata T., Nagata H., Okamoto Y., and Ito H. Preoperative radiation therapy for carcinoma of the oropharynx: prognostic factors for locoregional control and survival. In Vivo 17 (2003) 239-244
52. Valente G., Vercellino V., Corradi L., Tardy A., Bertetto O., Pomatto E., and Palestro G. Histopathological findings after preoperative chemo-radiotherapy in oral and oropharyngeal carcinoma. A study of 28 resected specimens. Eur J Cancer B Oral Oncol 29B (1993) 113-117
53. Wanebo H., Chougule P., Ready N., Safran H., Ackerley W., Koness R.J., McRae R., Nigri P., Leone L., Radie-Keane K., Reiss P., and Kennedy T. Surgical resection is necessary to maximize tumour control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 8 (2001) 644-650
54. Wanebo H.J., Chougule P., Akerley III W.L., Koness R.J., McRae R., Nigri P., Leone L., Ready N., Safran H., Webber B., and Cole B. Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. Am J Surg 174 (1997) 518-522
55. Warnakulasuriya S. Global trends in the epidemiology of oral cancer: the current position. Oral Oncol 1 Suppl (2005) 27
56. Wennerberg J. Pre versus post-operative radiotherapy of resectable squamous cell carcinoma of the head and neck. Acta Otolaryngol 115 (1995) 465-474
57. Zamboglou N., Schnabel T., Kolotas C., Achterrath W., Strehl H., Dalhauser S., and Vogt H.G. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience. Semin Oncol 21 Suppl 12 (1994) 45-53